RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Proto Script Pharmaceutical Stock

Proto Script Pharmaceutical Revenue 2024

Proto Script Pharmaceutical Revenue

788,960 USD

Ticker

PSCR

ISIN

US74373V1052

In 2024, Proto Script Pharmaceutical's sales reached 788,960 USD, a 0% difference from the 0 USD sales recorded in the previous year.

The Proto Script Pharmaceutical Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2016788.9671,55
2015--
2014--
2013--
2012--
2011--
2010--

Proto Script Pharmaceutical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Proto Script Pharmaceutical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Proto Script Pharmaceutical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Proto Script Pharmaceutical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Proto Script Pharmaceutical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Proto Script Pharmaceutical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Proto Script Pharmaceutical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Proto Script Pharmaceutical’s growth potential.

Proto Script Pharmaceutical Revenue, EBIT and net profit per share

DateProto Script Pharmaceutical RevenueProto Script Pharmaceutical EBITProto Script Pharmaceutical Net Income
2016788,960 undefined-298,080 undefined-7.18 M undefined
20150 undefined-33,140 undefined-33,140 undefined
20140 undefined-45,180 undefined-45,180 undefined
20130 undefined-38,260 undefined-38,260 undefined
20120 undefined-32,420 undefined-32,420 undefined
20110 undefined-32,850 undefined-32,850 undefined
20100 undefined0 undefined0 undefined

Proto Script Pharmaceutical stock margins

The Proto Script Pharmaceutical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Proto Script Pharmaceutical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Proto Script Pharmaceutical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Proto Script Pharmaceutical's sales revenue. A higher gross margin percentage indicates that the Proto Script Pharmaceutical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Proto Script Pharmaceutical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Proto Script Pharmaceutical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Proto Script Pharmaceutical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Proto Script Pharmaceutical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Proto Script Pharmaceutical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Proto Script Pharmaceutical Margin History

Proto Script Pharmaceutical Gross marginProto Script Pharmaceutical Profit marginProto Script Pharmaceutical EBIT marginProto Script Pharmaceutical Profit margin
201671.55 %-37.78 %-910.4 %
201571.55 %0 %0 %
201471.55 %0 %0 %
201371.55 %0 %0 %
201271.55 %0 %0 %
201171.55 %0 %0 %
201071.55 %0 %0 %

Proto Script Pharmaceutical Aktienanalyse

What does Proto Script Pharmaceutical do?

Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Proto Script Pharmaceutical's Sales Figures

The sales figures of Proto Script Pharmaceutical originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Proto Script Pharmaceutical’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Proto Script Pharmaceutical's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Proto Script Pharmaceutical’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Proto Script Pharmaceutical stock

How much revenue did Proto Script Pharmaceutical generate this year?

Proto Script Pharmaceutical has achieved a revenue of 788,960 USD this year.

How much was the turnover of the company Proto Script Pharmaceutical compared to the previous year?

The revenue of Proto Script Pharmaceutical has increased by 0% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Proto Script Pharmaceutical?

The revenue of Proto Script Pharmaceutical is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Proto Script Pharmaceutical measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Proto Script Pharmaceutical so important for investors?

The revenue of Proto Script Pharmaceutical is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Proto Script Pharmaceutical pay?

Over the past 12 months, Proto Script Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Proto Script Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of Proto Script Pharmaceutical?

The current dividend yield of Proto Script Pharmaceutical is .

When does Proto Script Pharmaceutical pay dividends?

Proto Script Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Proto Script Pharmaceutical?

Proto Script Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Proto Script Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Proto Script Pharmaceutical located?

Proto Script Pharmaceutical is assigned to the '-' sector.

Wann musste ich die Aktien von Proto Script Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Proto Script Pharmaceutical from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Proto Script Pharmaceutical pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Proto Script Pharmaceutical in the year 2023?

In the year 2023, Proto Script Pharmaceutical distributed 0 USD as dividends.

In which currency does Proto Script Pharmaceutical pay out the dividend?

The dividends of Proto Script Pharmaceutical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Proto Script Pharmaceutical

Our stock analysis for Proto Script Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Proto Script Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.